Stay updated on Maintenance Vadadustat in Dialysis-dependent CKD Clinical Trial
Sign up to get notified when there's something new on the Maintenance Vadadustat in Dialysis-dependent CKD Clinical Trial page.

Latest updates to the Maintenance Vadadustat in Dialysis-dependent CKD Clinical Trial page
- CheckyesterdayChange DetectedThe webpage has been updated to include new facility names and locations, particularly in South Korea, Brazil, and various other countries, while also adding drug information for Vadadustat and Chronic Kidney Disease. Notably, some previously listed locations and drug information for Darbepoetin Alfa have been removed.SummaryDifference17%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.0%
- Check29 days agoChange DetectedThe web page has been updated to a new version (v2.16.10), and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.5%
- Check36 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.0%
Stay in the know with updates to Maintenance Vadadustat in Dialysis-dependent CKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Maintenance Vadadustat in Dialysis-dependent CKD Clinical Trial page.